Literature DB >> 20040091

Doubtful outcome of the validation of the Rome II questionnaire: validation of a symptom based diagnostic tool.

Herdis K M Molinder1, Lars Kjellström, Henry B O Nylin, Lars E Agréus.   

Abstract

BACKGROUND: Questionnaires are used in research and clinical practice. For gastrointestinal complaints the Rome II questionnaire is internationally known but not validated. The aim of this study was to validate a printed and a computerized version of Rome II, translated into Swedish. Results from various analyses are reported.
METHODS: Volunteers from a population based colonoscopy study were included (n = 1011), together with patients seeking general practice (n = 45) and patients visiting a gastrointestinal specialists' clinic (n = 67). The questionnaire consists of 38 questions concerning gastrointestinal symptoms and complaints. Diagnoses are made after a special code. Our validation included analyses of the translation, feasibility, predictability, reproducibility and reliability. Kappa values and overall agreement were measured. The factor structures were confirmed using a principal component analysis and Cronbach's alpha was used to test the internal consistency. RESULTS AND DISCUSSION: Translation and back translation showed good agreement. The questionnaire was easy to understand and use. The reproducibility test showed kappa values of 0.60 for GERS, 0.52 for FD, and 0.47 for IBS. Kappa values and overall agreement for the predictability when the diagnoses by the questionnaire were compared to the diagnoses by the clinician were 0.26 and 90% for GERS, 0.18 and 85% for FD, and 0.49 and 86% for IBS. Corresponding figures for the agreement between the printed and the digital version were 0.50 and 92% for GERS, 0.64 and 95% for FD, and 0.76 and 95% for IBS. Cronbach's alpha coefficient for GERS was 0.75 with a span per item of 0.71 to 0.76. For FD the figures were 0.68 and 0.54 to 0.70 and for IBS 0.61 and 0.56 to 0.66. The Rome II questionnaire has never been thoroughly validated before even if diagnoses made by the Rome criteria have been compared to diagnoses made in clinical practice.
CONCLUSION: The accuracy of the Swedish version of the Rome II is of doubtful value for clinical practice and research. The results for reproducibility and reliability were acceptable but the outcome of the predictability test was poor with IBS as an exception. The agreement between the digital and the paper questionnaire was good.

Entities:  

Mesh:

Year:  2009        PMID: 20040091      PMCID: PMC2806864          DOI: 10.1186/1477-7525-7-106

Source DB:  PubMed          Journal:  Health Qual Life Outcomes        ISSN: 1477-7525            Impact factor:   3.186


  24 in total

1.  Rome? Manning? Who cares?

Authors:  L Agréus
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

2.  Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters.

Authors:  S Lydeard; R Jones
Journal:  J R Coll Gen Pract       Date:  1989-12

3.  Medical assessment by a Delphi group opinion technic.

Authors:  A V Milholland; S G Wheeler; J J Heieck
Journal:  N Engl J Med       Date:  1973-06-14       Impact factor: 91.245

4.  The cost of gastro-oesophageal reflux disease, dyspepsia and peptic ulcer disease in Sweden.

Authors:  Lars Agréus; Lars Borgquist
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  The intensity and variability of symptoms in dyspepsia.

Authors:  T Johannessen; H Petersen; P Kristensen; P M Kleveland; J Dybdahl; A K Sandvik; E Brenna; H Waldum
Journal:  Scand J Prim Health Care       Date:  1993-03       Impact factor: 2.581

Review 6.  Review of the quality of life and burden of illness in gastroesophageal reflux disease.

Authors:  Ingela Wiklund
Journal:  Dig Dis       Date:  2004       Impact factor: 2.404

7.  [A comparison between Rome III and Rome II criteria in diagnosing irritable bowel syndrome].

Authors:  An-jiang Wang; Xian-hua Liao; Pin-jin Hu; Si-chun Liu; Li-shou Xiong; Min-hu Chen
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2007-08

8.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11

9.  Diagnosing irritable bowel syndrome: poor agreement between general practitioners and the Rome II criteria.

Authors:  P O Vandvik; L Aabakken; P G Farup
Journal:  Scand J Gastroenterol       Date:  2004-05       Impact factor: 2.423

10.  Prevalence of symptoms of dyspepsia in the community.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1989-01-07
View more
  1 in total

1.  Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.

Authors:  Brjánn Ljótsson; Michael Jones; Nicholas J Talley; Lars Kjellström; Lars Agréus; Anna Andreasson
Journal:  United European Gastroenterol J       Date:  2020-01-14       Impact factor: 4.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.